 |
|
|
|
| Selected Reading |
 ABT Associates. The economic impacts of bioterrorist attacks on freight transport systems in an age of seaport vulnerability. Prepared for the US Dept of Transportation's Volpe National Transportation Systems Center. May 9, 2003 [Full text]
ACEP (American College of Emergency Physicians). The national report card on the state of emergency medicine: evaluating the environment of emergency care systems state by state. Jan 2006 [Full text]
Advisory Panel to Assess Domestic Response Capabilities for Terrorism Involving Weapons of Mass Destruction (Gilmore Commission). Assessing the threat. Dec 15, 1999 [Full text - Note: 123-page document; may load slowly]
AHA (American Hospital Association). Hospital preparedness for mass casualties. Aug 2000 [Full text]
AHRQ (Agency for Healthcare Research and Quality). Bioterrorism preparedness and response: use of information technologies and decision support systems. AHRQ Pub No. 02-E027, Jun 2002 [Summary]
AHRQ (Agency for Healthcare Research and Quality). Community-based mass prophylaxis: a planning guide for public health preparedness. AHRQ Pub No. 04-0044. Aug 2004 (released Sep 2004) [Full text]
AHRQ (Agency for Healthcare Research and Quality). Responding to bioterrorism: AHRQ helps clinicians, health systems, and policymakers. Oct 2001 [Full text]
AHRQ (Agency for Healthcare Research and Quality). Training of clinicians for public health events relevant to bioterrorism preparedness. AHRQ Pub No. 02-E007, Dec 2001 [Summary]
Alexander GC, Larkin GL, Wynia MK. Physicians' preparedness for bioterrorism and other public health priorities. Acad Emerg Med 2006 Nov;13(11):1238-41 [Abstract]
Alexander GC, Wynia MK. Ready and willing? Physicians' sense of preparedness for bioterrorism. Health Affairs 2003 Sep 9;22(5):180-97 [Abstract]
Alibek K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world—told from the inside by the man who ran it. New York: Random House, 1999
AMA, APHA (American Medical Association, American Public Health Association). Improving health system preparedness for terrorism and mass casualty events: recommendations for action. Released Jul 18, 2007 [Full text]
American Academy of Pediatrics Committee on Environmental Health and Committee on Infectious Diseases. Chemical-biological terrorism and its impact on children: a subject review. Pediatrics 2000;105(3 Pt 1)662-70 [Abstract]
APIC/CDC. Bioterrorism readiness plan: a template for healthcare facilities. Apr 13, 1999 [Full text]
Armstrong R, Coomber P, Prior S, et al. Looking for trouble: a policymaker's guide to biosensing. National Defense University. Released Jul 2004 [Full text]
Ashford DA, Kaiser RM, Bales ME, et al. Planning against biological terrorism: lessons from outbreak investigations. Emerg Infect Dis 2003 May;9(5):515-9 [Full text]
ASTHO (Association for State and Territorial Health Officers). Top 10 suggestions from state health officials who've been there. Jan 15, 2002 [Full text]
ASTHO (Association of State and Territorial Health Officials). State public health employee worker shortage report: a civil service recruitment and retention crisis. 2004 [Full text]
ASTHO, APHL, CSTE, NACCHO. Public health emergency preparedness: six years of achievement. Sep 29, 2008 [Full text]
Atlas RM. National security and the biological research community. Science 2002 Oct 25;298:753-4 [Abstract]
Atlas RM. The medical threat of biological weapons. Crit Rev Microbiol 1998;24(3):157-68 [Abstract]
Auf der Heide E. Disaster response: principles of preparation and coordination. St Louis, Mo: Mosby, 1989
Aylwin CJ, Konig TC, Brennan NW, et al. Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005. Lancet 2006 Dec 23;368(9554):2219-25 [Abstract]
Bannister B, Puro V, Fusco FM, et al. Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Lancet Infect Dis 2009 Jan;9(1):45-56 [Abstract]
Barbera J, Macintyre A, Gostin L, et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. JAMA 2001;286(21):2711-7 [Full text]
Barthell EN, Cordell WH, Moorhead JC, et al. The frontlines of medicine project: a proposal for the standardized communication of emergency department data for public heatlh uses including syndromic surveillance for biological and chemical terrorism. Ann Emerg Med 2002 Apr;39(4):422-9 [Abstract]
BCST (Board on Chemical Sciences and Technology), BLS (Board on Life Sciences). A framework for assessing the health hazard posed by bioaerosols. Washington, DC: National Academies Press, 2008 (prepublication copy, published online Sep 24) [Full text]
Bennett BW, Kaufman J, Byrnes J, et al. Early observations on possible defenses by the emerging threat agent project. Rand National Defense Research Institute. Jan 21, 2011 [Abstract]
Bhattacharjee Y. Bioterrorism: panel provides peer review of intelligence research. Science 2007 Dec 7;318(5856):1538 [Abstract]
Bhattacharjee Y. Bioweapons: Panel wants US program to retain its Russian roots. Science 2007 Sep 28;317(5846):1845 [Summary]
Blendon RJ, DesRoches CM, Cetron MS, et al. Attitudes toward the use of quarantine in a public health emergency in four countries. Health Aff 2006;25(2):15-25 [Abstract]
Blix H. Weapons of terror: freeing the world of nuclear, biological and chemical arms. WMDC (Weapons of Mass Destruction Commission) final report. Jun 1, 2006 [Full text]
BMA (British Medical Association). Biotechnology, weapons & humanity II. Oct 2004 [Link to order report]
Bork KH, Halkjaer-Knudsen V, Hansen JES, et al. Biosecurity in Scandinavia. Biosecur Bioterror 2007 Apr;5(1):62-71 [Abstract]
Bossi P, Tegnell A, Baka A, et al, for Task Force on Biological and Chemical Agent Threats (BICHAT), European Commission. BICHAT guidelines pertaining to bioterrorism. Eurosurveillance Monthly 2004 Dec;9(12):pii=499 [Full text]
Brandeau ML, Zaric GS, Freiesleben J, et al. An ounce of prevention is worth a pound of cure: improving communication to reduce mortality during bioterrorism responses. Am J Disaster Med 2008 Mar-Apr;3(2):65-78 [Abstract]
Braun BI, Darcy L, Divi C, et al. Hospital bioterrorism preparedness linkages with the community: improvements over time. Am J Infect Control 2004 Oct;32(6):317-26 [Abstract]
Bravata DM, McDonald KM, Smith WM, et al. Systematic review: surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med 2004 Jun 1;140(11):910-22 [Full text]
Bravata DM. Evaluating detection and diagnostic decision support systems for bioterrorism response. Emerg Infect Dis 2004 Jan 10(1):100-8 [Full text]
Bronze MS, Greenfield RA. Therapeutic options for diseases due to potential viral agents of bioterrorism. Curr Opin Investig Drugs 2003 Feb;4(2):172-8 [Abstract]
Bronze MS, Huycke MM, Machado LJ, et al. Viral agents as biological weapons and agents of bioterrorism. Am J Med Sci 2002 Jun;323(6):316-25 [Abstract]
Bruce J. Bioterrorism meets privacy: an analysis of the Model State Emergency Health Powers Act and the HIPAA privacy rule. Ann Health Law 2003;12(1):75-120 [Abstract]
Budowle B, Schutzer SE, Einseln A, et al. Building microbial forensics as a response to bioterrorism. Science 2003 Sep 26;301(5641):1852-3 [Abstract]
Buehler JW, Berkelman RL, Hartley DM, et al. Syndromic surveillance and bioterrorism-related epidemics. (Perspective) Emerg Infect Dis 2003 Oct;9(10):1197-1204 [Full text - See also Dembek below]
Burger KM, Leshner AI. New rules for biosecurity. (Editorial) Science 2009 May 29;324(5931):1117 [Abstract]
Burkle FM. Population-based triage management in response to surge-capacity requirements during a large-scale bioevent disaster. Acad Emerg Med 2006 Nov;13(11):1118-29 [Abstract]
Campbell P, Frances J, Meit M. Preparing for public health emergencies: meeting the challenges in rural America. Conference proceedings and recommendations from meeting Sep 27-28, 2004 [Full text]
Canadian Standing Senate Committee on National Security and Defence. National emergencies: Canada's fragile front lines. Mar 2004 [Full text]
Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weaspons. Emerg Infect Dis 2002 Aug;8(8):833-41 [Full text]
CDC Office of Public Health Preparedness and Response. Public health preparedness capabilities: national standards for state and local planning. Published Mar 25, 2011 [Full text]
CDC. Assessment of epidemiologic capacity in state and territorial health departments: United States, 2004. MMWR 2005 May 13;54(18):457-9 [Full text]
CDC. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC strategic planning workgroup. MMWR 2000:49(RR04):1-14 [Full text]
CDC. Cities readiness initiative - Q & A. Updated Jun 2005 [Full text]
CDC. Emergency use authorization online course. June 25, 2009 [Full text]
CDC. Improvement in local public health preparedness and response capacity: Kansas, 2002-2003. MMWR 2005 May 13;54(18):461-2 [Full text]
CDC. Interim recommendations for the selection and use of protective clothing and respirators against biological agents. Oct 25, 2001 [Full text]
CDC. Laboratory security and emergency response guidance for laboratories working with select agents. MMWR 2002 Dec 6;51(RR-19):1-6 [Full text]
CDC. Laboratory-acquired human glanders--Maryland, May 2000. MMWR 2000;49(24):532-5 [Full text]
CDC. Letter from Dr. Gerberding regarding CDC reorganization. Apr 21, 2005 [Letter with links]
CDC. Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management. MMWR 2004 Jun 11;53(RR08):1-27 [Full text]
CDC. Public health emergency response guide for state, local, and tribal public health directors--version 2.0. Jul 27, 2011 [Full text]
CDC. Public health infrastructure, May 14, 2002 [Press release]
CDC. Public health preparedness: 2011 state-by-state update on laboratory capabilities and response readiness planning. Sep 20, 2011 [Full text]
CDC. Public health preparedness: mobilizing state by state. Feb 20, 2008 [Full text]
CDC. Public health preparedness: strengthening CDC's emergency response. Jan 16, 2009 [Link to full text]
CDC. Public health preparedness: strengthening the nation's emergency response state by state. Sep 21, 2010 [Full text]
CDC. States receive $40 million for stronger public health preparedness for bioterrorism. CDC Web site. Sep 15, 1999 press release [Full text]
CDC. Surveillance for early detection of disease outbreaks at an outdoor mass gathering: Virginia, 2005. MMWR 2006 Jan 27;55(03):71-4 [Full text]
CDC. Syndromic surveillance for bioterrorism following the attacks on the World Trade Center–New York City, 2001. MMWR 2002 Sep 11;51(Special Issue):13-5 [Full text]
CDC. Syndromic surveillance: reports from a national conference, 2003. MMWR 2004 Sep 24;53(suppl) [Full text]
CDC. Syndromic surveillance: reports from a national conference, 2004. MMWR 2005 Aug 26;54(Suppl) [Full text]
CDC. Terrorism and emergency preparedness in state and territorial public health departments: United States, 2004. MMWR 2005 May 13;54(18):459-60 [Full text]
CDC. Terrorism preparedness in state health departments: United States, 2001-2003. MMWR 2003 Oct 31;52(43):1051-3 [Full text]
CDC. Rapid assessment of injuries among survivors of the terrorist attack on the World Trade Center–New York City, September 2001 [Full text]
Chamberlain A, Gronvall GK. Immune-boosting adjuvants. Biosecur Bioterror 2007 Sep;5(3):202-5 [Extract]
Chandler D, Landrigan I. A journalist's guide to covering bioterrorism. Ed 2. Radio and Television News Directors Foundation. 2004 [Full text]
Chang M, Glynn MK, Groseclose SL. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis 2003 May:9(5):556-64 [Full text]
Charatan F. US plans drugs stockpile to counter bioterrorism threat. BMJ 2000 May 6;320(7244):1225 [Full text]
Christopher GW, Cieslak TH, Pavlin JA, et al. Biological warfare: a historical perspective. JAMA 1997;278(5):412-7 [Abstract]
Cieslak TH, Christopher GW, Kortepeter MG, et al. Immunization against potential biological warfare agents. Clin Infect Dis 2000 Jun;30(6):843-50 [Abstract]
Clarke RA, Rudman WB, and the Independent Task Force on Emergency Responders. Emergency responders: drastically underfunded, dangerously unprepared. Sponsored by Council on Foreign Relations. Released Jun 29, 2003 [Summary, transcript, and order]
Clarke TL, Rotarius T, Liberman A, et al. Responding to a bioterrorism attack - one scenario: part 1. Health Care Manag (Frederick) 2008 Jul/Sep;27(3):192-211 [Abstract]
Clements B, Evans RG. The doctor's role in bioterrorism. Lancet 2004;364(1 Suppl):26-7 [Listing]
Cole TB. Medical news & perspectives: when a bioweapon strikes, who will be in charge? JAMA 2000;284(8):944-8 [Full text]
Colmers JM, Fox DM. The politics of emergency health powers and the isolation of public health. Am J Public Health 2003 Mar;93(3):397-9 [Abstract]
Commission on the Intelligence Capabilities of the United States Regarding Weapons of Mass Destruction. The changing proliferation threat and the intelligence response. Chap 13 of Report to the President, Mar 31, 2005 [Full text - See especially pp 503-16 regarding biological weapons]
Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism (US). Prevention of WMD proliferation and terrorism report card. Jan 26, 2010 [Full text]
Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism. World at risk: the report of the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism. Dec 2, 2008 [Full text]
Cono J, Cragan JD, Jamieson DJ, et al. Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis 2006;12(11):1631-7 [Full text]
Cosgrove SE, Jenckes MW, Wilson LM, et al. Tool for evaluating core elements of hospital disaster drills. AHRQ Publication No. 08-0019, Jun 2008 [Full text]
CRS (Congressional Research Service). Project BioShield: authorities, appropriations, acquisitions, and issues for Congress. Mar 3, 2011 [Full text]
Crutchley TM, Rodgers JB, Whiteside HP, et al. Agroterrorism: Where are we going in the ongoing war on terrorism? J Food Prot 2007 Mar;70(3):791-804 [Abstract]
Danzig R. Catastrophic bioterrorism -- what is to be done? Washington, DC: Center for Technology and National Security Policy, National Defense University, Aug 2003 [Full text]
Daschle T, Inglesby T. Foreword: necessary progress in biosecurity. Harv Law Policy Rev 2010 (published online Jun 27) [Full text]
Dausey DJ, Lurie N, Diamond A. Public health response to urgent case reports. Health Affairs 2005 Aug 30:W5-412-9 [Abstract]
De Micheli V, Raso R Tiberti D, et al, for the Epidemiological Consultation Team. Surveillance system in place for the 2006 Winter Olympic Games, Torino, Italy, 2006. Eurosurveillance Weekly 2006 Feb 9:11(2):pii=2897 [Full text]
Deisler PF Jr. A perspective: risk analysis as a tool for reducing the risks of terrorism. Risk Anal 2002 Jun;22(3):405-13 [Abstract]
Dembek AF, Cochrane DG, Pavlin JA. Syndromic surveillance. (Letter) Emerg Infect Dis 2004 Jul;10(7):1333-5 [Full text - Comment on Buehler article above]
Dembek ZF, Kortepeter MG, Pavlin JA. Discernment between deliberate and natural infectious disease outbreaks. Epidemiol Infect 2007 Aor;135(3):353-71 [Abstract]
Department of Homeland Security. Review of national bio and agro-defense facility site selection process. Nov 2010 [Full text]
DHHS. Biennial implementation plan for the national health security strategy of the United States of America. (Draft) Jul 19, 2010 [Full text]
DHS. Creating a culture of preparedness among schools. Released Oct 30, 2007 [Full text]
DHS. National infrastructure protection plan. Released Jun 30, 2006 [Links to full text & executive summary]
DHS. National preparedness guidelines. Released Sep 13, 2007 [Full text]
DHS. National Response Framework. Released Jan 22, 2008 (replaces National Response Plan from 2005) [Full text]
DHS. National Response Framework. Released Jan 6, 2005 [DHS page with links to base and full documents]
DHS. Nationwide plan review phase 2 report. Jun 16, 2006 [Full text]
DHS. One year later--implementing the biosurveillance requirements of the 9/11 Act. Joint statement of Hooks R, Myers E, Stiefel J, Office of Health Affairs, before the House Committee on Homeland Security. Jul 16, 2008 [Full text]
DHS. Strategy to enhance international supply chain security. Released Jul 2007 [Full text]
DHS. TOPOFF 2: after action summary report. Dec 19, 2003 [Full text]
DHS. Transcript of background briefing with senior DHS officials on TOPOFF 3. Apr 8, 2005 [Full text]
DiGiovanni C, Reynolds B, Harwell R, et al. Community reaction to bioterrorism: prospective study of simulated outbreak. Emerg Infect Dis 2003 Jun 9(6):708-12 [Full text]
Dudley JP. New challenges for public health care: biological and chemical weapons awareness, surveillance, and response. Biol Res Nurs 2003 Apr;4(4):244-50 [Abstract]
Dworkin MS, Ma X, Golash RG. Fear of bioterrorism and implications for public health preparedness. Emerg Infect Dis 2003 Apr;9(4):503-5 [Full text]
Eisenman DP, Wold C, Setodji C, et al. Will public health's response to terrorism be fair? Racial/ethnic variations in perceived fairness during a bioterrorist event. Biosecur Bioterror 2004;2(3):146-56 [Abstract]
Emanuel P, Jones F, Smith M, et al. The key to enabling biosurveillance is cooperative technology development. Biosecur Bioterror 2011 (published online Nov 7) [Abstract]
Engel CC, Locke S, Reissman DB, et al. Terrorism, trauma, and mass casualty triage: how might we solve the latest mind-body problem? Biosecur Bioterror 2007 Jun;5(2):155-63 [Abstract]
EPA. Comparison of ultrafiltration techniques for recovering biothreat agents in water. EPA/600/R-11/103 2011 (published Oct 17) [Full text]
EPA. EPA's BioWatch role reduced. Evaluation report No. 10-P-0106. Apr 20, 2010 [Full text]
EPA. EPA's fact sheet on LEPCs and deliberate releases: addressing terrorist activities in the Local Emergency Plan. Aug 2001 [Full text]
EPA. EPA's role in counter-terrorism activities: fact sheet. Feb 1998 [Full text]
EPA. Results from persistence testing of biological agents under various conditions. May 31, 2011 [Full text]
European Council. Draft: EU strategy against proliferation of weapons of mass destruction. Adopted Dec 12, 2003 [Full text]
Eurosurveillance Editorial Team. European Commission launches Green Paper on bio-preparedness. Eurosurveillance Weekly 2007 Aug 16;12(8):pii=3251 [Full text]
Evans RG, Crutcher JM, Shadel B, et al. Terrorism from a public health perspective. Am J Med Sci 2002 Jun;323(6):291-8 [Abstract]
Executive Order establishing Office of Homeland Security Oct 2001 [Full text]
FDA. Advancing regulatory science for public health: a framework for FDA's regulatory science initiative. Released Oct 6, 2010 [Full text]
Fine A, Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis 2001 Jan 15;32(2):277-82 [Abstract]
Franco C, Bouri N. Environmental decontamination following a large-scale bioterrorism attack: federal progress and remaining gaps. Biosecur Bioterror 2010 Jun 22;8(2):107-17 [Abstract]
Franco C, Deitch S. Billions for biodefense: federal agency biodefense funding, FY2007-FY2008. Biosecur Bioterror 2007 Jun;5(2):117-33 [Full text]
Franco C, Sell TK. Federal agency biodefense funding, FY2010-FY2011. Biosecur Bioterror 2010 Jun 22;8(2):129-49 [Abstract]
Franco C, Sell TK. Federal agency biodefense funding, FY2011-FY2012. Biosecur Bioterror 2011 May 25;9(2):117-37 [Abstract]
Franco C. Billions for defense: federal agency biodefense funding, FY2008-FY2009. Biosecur Bioterror 2008 Jun;6(2):131-46 [Full text]
Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278(5):399-411 [Abstract]
Freedman A, Afonja O, Chang MW, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002;287:869-74 [Full text]
Fry-Pierce CC, Jenze PE. Bioterrorism and U.S. domestic preparedness: bureaucratic fragmentation and American vulnerability. J Homeland Secur Emerg Manag 2011 Jan;8(1):39 [Abstract]
GAO (US Government Accountability Office). Biosafety laboratories: perimeter security assessment of the nation's five BSL-4 laboratories. GAO-08-1092. Released Oct 16, 2008 (but dated Sep 17) [Full text]
GAO (General Accounting Office) Better guidance is needed to improve communication should anthrax contamination occur in the future. GAO-03-316. Apr 2003 [Full text]
GAO (General Accounting Office). Bioterrorism preparedness efforts have improved public health response capacity, but gaps remain. Testimony of Janet Heinrich before House Committee on Government Reform. GAO-03-654T. Apr 9, 2003 [Full text]
GAO (General Accounting Office). Bioterrorism: Coordination and preparation. Testimony of Janet Heinrich, Director, Health Care - Public Health Issues. GAO-02-129T. Oct 5, 2001 [Full text]
GAO (General Accounting Office). Bioterrorism: Federal research and preparedness activities. Report to Congressional committees. GAO-01-915. Oct 16, 2001 [Full text]
GAO (General Accounting Office). Bioterrorism: information technology strategy could strengthen federal agencies' abilities to respond to public health emergencies. Report to Congressional Requestors. GAO-03-139. May 30, 2003 [Full text]
GAO (General Accounting Office). Bioterrorism: preparedness varied across state and local jurisdictions. GAO-03-373. Apr 8, 2003 [Full text]
GAO (General Accounting Office). Bioterrorism: Review of public health preparedness programs. Testimony of Janet Heinrich, Director, Health Care - Public Health Issues. GAO-02-149T. Oct 10, 2001 [Full text]
GAO (General Accounting Office). Bioterrorism: The Centers for Disease Control and Prevention's role in public health protection. Testimony of Janet Heinrich, Director, Health Care - Public Health Issues. GAO-02-235T. Nov 15, 2001 [Full text]
GAO (General Accounting Office). Centers for Disease Control and Prevention: Agency leadership taking steps to improve management and planning, but challenges remain. GAO-04-219. Jan 2004 [Full text]
GAO (General Accounting Office). Combating terrorism: evaluation of selected characteristics in national strategies related to terrorism. Statement of Randall A Yim, Managing Director, Homeland Security and Justice Issues. GAO-04-408T. Feb 3, 2004 [Full text]
GAO (General Accounting Office). HHS bioterrorism preparedness programs: states reported progress but fell short of program goals for 2002. GAO-04-36OR. Feb 10, 2004 [Full text]
GAO (General Accounting Office). Homeland Security: new department could improve coordination but transferring control of certain public health programs raises concerns. Testimony of Janet Heinrich, Director, Health Care - Public Health Issues. GAO-02-954T. Jul 16, 2002 [Full text]
GAO (General Accounting Office). Hospital preparedness: most urban hospitals have emergency plans but lack certain capacities for bioterrorism response. GAO-03-924. Aug 2003 [Full text]
GAO (General Accounting Office). Infectious diseases: gaps remain in surveillance capabilities of state and local agencies. Testimony of Janet Heinrich before HR Subcommittee on Emergency Preparedness and Response, Select Committee on Homeland Security. GAO-03-1176T. Sep 24, 2003 [Full text]
GAO (General Accounting Office). Status of key recommendations GAO has made to DHS and its legacy agencies. GAO-04-865R. Jul 2, 2004 (reissued Aug 13, 2004) [Full text]
GAO (Government Accountability Office). Public health preparedness: developing and acquiring medical countermeasures against chemical, biological, radiological, and nuclear agents. GAO-11-567T. Apr 13, 2011 [Full text]
GAO (US Government Accountability Office). Biosafety laboratories: BSL-4 laboratories improved perimeter security despite limited action by CDC. GAO-09-851. Released Aug 6, 2009 (but dated Jul 7) [Full text]
GAO (US Government Accountability Office). Biosurveillance: Developing a collaboration strategy is essential to fostering interagency data and resource sharing. GAO-10-171. Dec 18, 2009 [Full text]
GAO (US Government Accountability Office). Biosurveillance: efforts to develop a national biosurveillance capability need a national strategy and a designated leader. GAO 10-645. Released Jul 1, 2010 [Full text]
GAO (US Government Accountability Office). Biosurveillance: nonfederal capabilities should be considered in creating a national biosurveillance strategy. GAO-12-55. Oct 31, 2011 [Full text]
GAO (US Government Accountability Office). Biosurveillance: preliminary observations on Department of Homeland Security's biosurveillance initiatives. GAO-08-960T. Jul 16, 2008 [Full text]
GAO (US Government Accountability Office). Critical infrastructure protection: sector plans and sector councils continue to evolve. GAO-07-706R. Jul 10, 2007 [Full text]
GAO (US Government Accountability Office). Critical infrastructure: sector plans complete and sector councils evolving. GAO-07-1075T. Jul 12, 2007 [Summary with links]
GAO (US Government Accountability Office). Department of Homeland Security: progress made and work remaining in implementing homeland security missions 10 years after 9/11. GAO-11-919T. Sep 7, 2011 [Full text]
GAO (US Government Accountability Office). Health information technology: more detailed plans needed for the Centers for Disease Control and Prevention's redesigned BioSense program. GAO-09-100. Nov 20, 2008 [Full text]
GAO (US Government Accountability Office). High-containment biosafety laboratories: preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States. GAO-08-108T. Congressional testimony released October 4, 2007 [Full text]
GAO (US Government Accountability Office). Homeland defense: planning, resourcing, and training issues challenge DOD's respond to domestic chemical, biological, radiological, nuclear, and high-yield explosive incidents. GAO-10-123. Oct 7, 2009 [Full text]
GAO (US Government Accountability Office). Homeland security: first responders' ability to detect and model hazardous releases in urban areas is significantly limited. GAO-08-180. Released Jun 27, 2008 [Full text]
GAO (US Government Accountability Office). Homeland Security: observations on DHS and FEMA efforts to prepare for and respond to major and catastrophic disasters and address related recommendations and legislation. GAO-07-1142T. Jul 31, 2007 [Full text]
GAO (US Government Accountability Office). National preparedness: improvements needed for acquiring medical countermeasures to threats from terrorism and other sources. GAO-12-121. Oct 26, 2011 [Full text]
GAO (US Government Accountability Office). Project Bioshield: HHS can improve agency internal controls for its new contracting authorities. GAO-09-820. Jul 21, 2009 [Full text]
GAO. Bioterrorism: information on jurisdictions' expenditure and reported obligation of program funds. GAO-05-239. Feb 28, 2005 [Full text]
GAO. Emerging infectious diseases: review of state and federal disease surveillance efforts. GAO-04-877. Sep 2004 [Full text]
Gaskins M, Rumm PD, Cummings CE, et al. Terrorism preparedness two years after Bioterrorism Preparedness Accountability Indicators Project. Homeland Security 2005 (published online Dec 7) [Full text]
Gemelas TC, Johnson M. Transportation security: a systems approach. J Homeland Security 2007 (published online Mar 1) [Full text]
Gibson S, Lemyre L, Clement M, et al. Terrorism threats and preparedness in Canada: the perspective of the Canadian public. Biosecur Bioterror 2007 Jun;5(2):134-44 [Abstract]
Gilfillan L, Smith BT, Inglesby TV, et al. Taking the measure of countermeasures: leaders' views on the nation's capacity to develop biodefense countermeasures. Biosecur Bioterror 2004;2(4):320-7 [Full text]
Gilsdorf JR, ZilinakA RA. New considerations in infectious disease outbreaks: the threat of genetically modified microbes. Clin Infect Dis 2005 Apr 15;40(8):1160-5 [Abstract]
Glass TA, Schoch-Spana M. Bioterrorism and the people: how to vaccinate a city against panic. Clin Infect Dis 2002 Jan 15;34(2):217-23 [Full text]
Gostin LO, Sapsin JW, Teret SP, et al. The Model State Emergency Health Powers Act: planning for and response to bioterrorism and naturally occurring infectious diseases. JAMA 2002 Aug 7:288(5):622-8 [Full text]
Goyal SM, Anantharaman S, Ramakrishnan MA, et al. Detection of viruses in used ventilation filters from two large public buildings. Am J Infect Control 2011 Sep;39(7):e30-8 [Abstract]
Graham B, Talent J. The threat of bioterrorism. (Editorial) Disaster Med Public Health Prep 2011 Sep;5(suppl 2):S170-1 [Full text]
Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002 Jun;323(6):326-40 [Abstract]
Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002 Jun;323(6):299-315 [Abstract]
Grieb J, Clark ME. Regional public health emergency preparedness: the experience of Massachusetts Region 4b. Public Health Rep 2008 Jul-Aug;123(4):45-60 [Abstract]
Gronvall GK, Fitzgerald J, Chamberlain A, et al. High-containment biodefense research laboratories: meeting report and center recommendations. Biosecur Bioterror 2007 Apr;5(1):75-85 [Full text]
Gronvall GK, Smith BT, Matheny J, et al. Biomedical Advanced Research and Development Authority (BARDA) roundtable. Biosecur Bioterror 2007 Jun;5(2):174-9 [Full text]
Grotto AJ, Tucker JB. Biosecurity: a comprehensive action plan. Center for American Progress. Jun 2006 [Full text]
Grow RW, Rubinson L. The challenge of hospital infection control during a response to bioterrorist attacks. Biosecurity and Bioterrorism 2003 1(3):215-20 [Citation]
Guillemin J. Anthrax: The investigation of a deadly outbreak. Berkeley, Calif: University of California Press, 1999
Gursky EA. Drafted to fight terror: U.S. public health on the front lines of biological defense. ANSER Aug 2004 [Full text]
Gursky EA. Hometown hospitals: the weakest link? Bioterrorism readiness in America's rural hospitals. National Defense University. Released Jul 14, 2004 [Abstract]
Hamburg MA. SARS threat preparedness. Testimony before Government Reform Committee, US House of Representatives, 108th Congress. Apr 9, 2003 [Full text]
Harbison S, Novak JC. Bioterrorism, children, and the United States' health and security. J Pediatr Health Care 2002 Sep-Oct;16(5):265-6 [Abstract]
Harris MD, Yeskey K. Bioterrorism and the vital role of family physicians. (Editorial) Am Fam Physician 2011 Jul 1;84(1):18-20 [Full text]
Hasset AL, Sigal LH. Unforeseen consequences of terrorism: medically unexplained symptoms in a time of fear. (Commentary) Arch Intern Med 2002 Sep 9;162(16):1809-13 [Abstract]
Henderson DA. Bioterrorism as a public health threat. Emerg Infect Dis 1998;4(3):488-92 [Full text]
Henderson DA. The looming threat of bioterrorism. Science 1999;283(5406):1279-82 [Abstract]
Henderson DA. The science of bioterrorism: HHS preparedness. Testimony before House Committee on Science. Dec 5, 2001 [Full text]
Heritage Foundation. Health care and homeland security: crossroads of emergency response. Special report #19. Jan 18, 2008 [Full text]
HHS Agency for Healthcare Research and Quality. Emergency preparedness atlas: US nursing home and hospital facilities. Released Jul 19, 2007 [Links to full text]
HHS Agency for Healthcare Research and Quality. Nursing homes in public health emergencies: special needs and potential roles. Released Jul 19, 2007 [Links to full text]
HHS. Fact sheet: 17 critical benchmarks for bioterrrorism preparedness planning. Jun 6, 2002 [Full text]
HHS. HHS public health emergency medical countermeasures enterprise strategy for chemical, biological, radiological and nuclear threats. Fed Regist 2007 Mar 20;72(53):13109-14 [Full text]
HHS. HIPAA privacy rule: disclosures for emergency preparedness - a decision tool. Released Jul 5, 2006 [Full text]
HHS. National health security strategy of the United States of America. Released Dec 29, 2009 [Full text]
HHS. Terrorism and other public health emergencies: a reference guide for the media. Sep 2005 [Full text]
HHS. The public health emergency medical countermeasures enterprise review. Report released Aug 19, 2010 [Full text]
Higgins W, Wainright C III, Lu N, et al. Assessing hospital preparedness using an instrument based on the Mass Casualty Disaster Plan Checklist: Results of a statewide survey. Am J Infect Control 2004 Oct;32(6):327-32 [Abstract]
Hilleman MR. Overview: cause and prevention in biowarfare and bioterrorism. Vaccine 2002 Aug 19;20(25-6):3055 [Abstract]
Hirschberg R, La Montagne J, Fauci AS. Biomedical research: an integral component of national security. N Engl J Med 2004 May 20;350(21):2119-21 [Full text]
Hodge JG Jr, Gostin LO, Vernick JS. The Pandemic and All-Hazards Preparedness Act: improving public health emergency response. (Commentary) JAMA 2007 Apr 18;297(15):1708-11 [Extract]
Hodge JG, Brown EF, O'Connell JP. The HIPAA privacy rule and bioterrorism planning, prevention, and response. Biosec Bioterr 2004;2(2):73-80 [Full text]
Hoffman MA, Wilkinson TH, Bush A, et al. Multijurisdictional approach to biosurveillance, Kansas City. Emerg Infect Dis 2003 Oct;9(10):1281-6 [Full text]
Hoffman RE, Norton JE. Lessons learned from a full-scale bioterrorism exercise. Emerg Infect Dis 2000;6(6)652-3 [Full text]
Hoffman RE. Preparing for a bioterrorist attack: legal and administrative strategies. (Perspective) Emerg Infect Dis 2003 Feb;9(2):241-5 [Full text]
Holloway JC, Norwood AE, Fullerton CS, et al. The threat of biological weapons: prophylaxis and mitigation of psychological and social consequences. JAMA 1997;278(5)425-7 [Abstract]
Hom GG. Chemical, biological, and radiological weapons: implications for optometry and public health. Optometry 2003 Feb;74(2):81-98 [Abstract]
Homeland Security Presidential Directive 8 (HSPD-8) National preparedness. Dec 17, 2003 [Full text]
Homeland Security Report, Feb 2002 (White House report of America's responses to date and President's national homeland security strategy) [Full text]
Hottes AK, Rusek B, Sharples F. Biosecurity challenges of the global expansion of high containment biological laboratories. National Research Council 2011 (published online Dec 19) [Abstract]
Hsu CE, Jacobson H, Feldman K, et al. Assessing bioterrorism preparedness and response of rural veterinarians: experiences and training needs. J Vet Med Ed 2008 Summer;35(2):262-8 [Abstract]
Huang Y. Managing biosecurity threats in China. Biosecur Bioterror 2011 Mar;9(1):31-40 [Abstract]
Hughes JM. The emerging threat of bioterrorism. Emerg Infect Dis 1999;5(4):494-5 [Full text]
Inglesby TV, O'Toole T, Henderson DA. Preventing the use of biological weapons: improving response should prevention fail. Clin Infect Dis 2000 Jun;30(6):926-9 [Full text]
Inglesby TV. Progress in disaster planning and preparedness since 2001. (Commentary) JAMA 2011 (published online Sep 8) [Full text]
Institute of Medicine. Preparing for terrorism: tools for evaluating the metropolitan medical response system program. Washington, DC: National Academy Press, 2002 [Full text]
IOM (Institute of Medicine) and NRC (National Research Council). Giving full measure to countermeasures: addressing problems in the DoD program to develop medical countermeasures against biological warfare agents. Prepublication version. Jan 2004 [Full text]
IOM (Institute of Medicine). BioWatch and public health surveillance: evaluating systems for the early detection of biological threats -- abbreviated version. Oct 7, 2010 [Full text]
IOM (Institute of Medicine). BioWatch and public health surveillance: evaluating systems for the early detection of biological threats. National Academies Press, Washington, DC. Dec 7, 2009 [Links to full text]
IOM (Institute of Medicine). Microbial threats to health: emergence, detection, and response. Mar 18, 2003 [Full text]
IOM (Institute of Medicine). Research priorities in emergency preparedness and response for public health systems: a letter report. Jan 22, 2008 [Links to free full text]
IOM. Hospital-based emergency care: at the breaking point. Prepublication proof. Jun 14, 2006 [Full text]
IOM. Medical countermeasures dispensing: emergency use authorization and the postal model: workshop summary. Washington, DC: National Academies Press, 2010 [Full text]
IOM. Public health risks of disasters: communication, infrastructure, and preparedness. Jan 25, 2005 [Full text]
IOM/NRC (Institute of Medicine/National Research Council). Effectiveness of national biosurveillance systems: BioWatch and the public health system: interim report. Feb 10, 2009 [Full text]
IOM/NRC (Institute of Medicine/National Research Council). Globalization, biosecurity, and the future of the life sciences. Prepublication copy. Washington, DC: National Academies Press, 2006 [Full text]
Jackson B, Peterson DJ, Bartis J, et al. Protecting emergency responders - lessons learned from terrorist attacks. Proceedings of a NIOSH-sponsored conference held Dec 9-11, 2001, in New York [Full text]
Jaeger PT, Fleischmann KR, Preece J, et al. Community response grids: using information technology to help communities respond to bioterror emergencies. Biosecur Bioterror 2007 Dec;5(4):335-46 [Abstract]
Joint Chiefs of Staff. Operations in chemical, biological, radiological, and nuclear (CBRN) environments. Joint Publ 3-11 2008 Aug 26. [Full text]
Jortani SA, Snyder JW, Valdes R. The role of the clinical laboratory in managing chemical or biological terrorism. Clin Chem 2000;46:1883-93 [Full text]
Kaiser J. Biosafety breaches: accidents spur a closer look at risks at biodefense labs. Science 2007 Sep 28;317(5846):1852-4 [Summary]
Kaiser R, Coulombier D, Baldari M, et al. What is epidemic intelligence, and how is it being improved in Europe? Eurosurveillance Weekly 2006 Feb 2;11(2):pii=2892 [Webpage]
Kaiser R, Coulombier D. Epidemic intelligence during mass gatherings. Eurosurveillance Weekly 2006 Dec 21;11(12):pii=3100 [Full text]
Kaplan EH, Patton CA, Fitzgerald WP, et al. Detecting bioterror attacks by screening blood donors: a best-case analysis. Emerg Infect Dis 2003 Aug;9(8):909-14 [Full text]
Karwa M, Bronzert P, Kvetan V. Bioterrorism and critical care. Crit Care Clin 2003 Apr;19(2):279-313 [Abstract]
Katz A, Staiti AB, McKenzie KL. Preparing for the unknown, responding to the known: communities and public health preparedness. Health Aff 2006 Jul/Aug;25(4):946-57 [Abstract]
Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997;3(2):83-94 [Full text]
Kaufmann AF, Pesik NT, Meltzer MI. Syndromic surveillance in bioterrorist attacks. (Commentary) Emerg Infect Dis 2005 Sep;11(9):1487-8 [Full text]
Kelen GD, Kraus CK, McCarthy ML, et al. Inpatient disposition classification for the creation of hospital surge capacity: a multiphase study. Lancet 2006 Dec 2;368(9551):1984-90 [Abstract]
Kelly CD, Egan C, Cirino NM. The Code Red solution: biothreat response training for first responders. Biosecur Bioterror 2006 Dec;4(4):391-6 [Abstract]
Khan AS, Morses S, Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet 2000;356(9236):1179-82 [Listing]
Lasker RD. Redefining readiness: terrorism planning through the eyes of the public. Center for the Advancement of Collaborative Strategies in Health. Sep 14, 2004 [Full text]
LaTourrette T, Peterson DJ, Bartis J, et al. Protecting emergency responders, volume 2: community views of safety and health risks and personal protection needs. Published by RAND for the National Institute for Occupational Health and Safety. Aug 20, 2003 [Full text]
Lazarus R, Kleinman K, Dashevsky I, et al. Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerg Infect Dis 2002 Aug;8(8):753-60 [Full text]
Le Duc JW, Anderson K, Bloom M, et al. Framework for leadership and training of Biosafety Level 4 laboratory workers. Emerg Infect Dis 2008 Nov;14(11):1685-8 [Full text]
Lee B, Gordon P, Moore JE 2nd, et al. Simulating the economic impacts of a hypothetical bio-terrorist attack: a sports stadium case. J Homeland Secur Emerg Manage 2008;5(1):39 (published online Aug 19) [Abstract]
Leitenberg M. Biological weapons and bioterrorism in the first years of the twenty-first century. Politics and Life Sciences 2002 Sep;21(2):3-27 [Abstract]
Lemieux P, Sieber R, Osborne A, et al. Destruction of spores on building decontamination residue in a commercial autoclave. Appl Environ Microbiol 2006 Dec;72(12):7687-93 [Abstract]
Leski TA, Lin B, Malanoski AP, et al. Testing and validation of high density resequencing microarray for broad range biothreat agents detection. PLoS ONE 2009 Aug 11;4(8):e6569 [Full text]
Li K, Thomasson D, Ketai L, et al. Potential applications of conventional and molecular imaging to biodefense research. Clin Infect Dis 2005 May 15;40(10):1471-80 [Abstract]
Lien O, Franco C, Gronvall GK, et al. Getting medicine to millions in a public health emergency: can retailers play a role? From University of Pittsburgh Medical Center. 2005 [Full text]
Lien O, Maldin B, Franco C, et al. Getting medicine to millions: new strategies for mass distribution. Biosec Bioterr 2006 Jun;4(2):176-82 [Abstract]
Lillibridge SR. Restructuring government for homeland security: nuclear/biological/chemical threats. Testimony before House Committee on Budget, Dec 5, 2001 [Full text]
Lim DV, Simpson JM, Kearns EA, et al. Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin Microbiol Rev 2005 Oct;18(4):583-607 [Abstract]
Lovelace K, Bibeau D, Gansneder B, et al. All-hazards preparedness in an era of bioterrorism funding. J Public Health Manage Pract 2007 Sep/Oct;13(5):465-9 [Abstract]
Luongo KN, Averre D, Della Ratta R, et al. Building a forward line of defense securing former Soviet biological weapons. Arms Control Today 2004 Jul/Aug;34(6) [Full text]
Lurie N, Valdez B, Wasserman J, et al. Public health preparedness in California: lessons learned from seven health jurisdictions. RAND Corp. Jun 2, 2004 [Abstract and link to full text]
M'Ikanatha NM, Lautenback E, Kunselman AR, et al. Sources of bioterrorism information among emergency physicians during the 2001 anthrax outbreak. Biosecurity Bioterrorism 2003;1(4):259-65 [Abstract]
M'ikanatha NM, Southwell B, Lautenback E. Automated laboratory reporting of infectious diseases in a climate of bioterrorism. Emerg Infect Dis 2003 Sep;9(9):1053-7 [Full text]
Macintyre AG, Christopher GW, Eitzen E Jr, et al. Weapons of mass destruction events with contaminated casualties--effective planning for health care facilities. JAMA 2000;283(2):242-9 [Abstract]
Madjid M, Lillibridge S, Mirhaji P, et al. Influenza as a bioweapon. J R Soc Med 2003;96(7):345-6 [Abstract]
Maher C, Lushniak BD. Availability of medical countermeasures for bioterrorism events: US legal and regulatory options. Clin Pharmacol Ther 2009 Jun;85(6):669-71 [Full text]
Mair JS, Mair M. Vaccine liability in the era of bioterrorism. Biosecurity and Bioterrorism 2003;1(3):169-84 [Full text]
Maldin B, Lam C, Franco C, et al. Regional approaches to hospital preparedness. Biosecur Bioterror 2007 Apr;5(1):43-54 [Full text]
Maldin-Morgenthau B, Toner E, Waldhorn R, et al. Roundtable: promoting partnerships for regional healthcare preparedness and response. Biosecur Bioterror 2007 Jun;5(2):180-5 [Full text]
Mangold T, Goldberg J. Plague wars: a true story of biological warfare. New York: St. Martin's Press, 1999
Mantke OD, Schmitz H, Zeller H, et al. Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill 2005 Jun;19(6):pii=545 [Full text]
Martin CO, Adams HP Jr. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol 2003 Jan;60(1):21-5 [Abstract]
Matheny J, Mair M, Mulcahy A, et al. Incentives for biodefense countermeasure development. Biosecur Bioterror 2007 Sep;5(3):228-38 [Abstract]
Matzo M, Wilkinson A, Lynn J, et al. Palliative care considerations in mass casualty events with scarce resources. Biosecur Bioterror 2009 Jul 27;7(20):199-210 [Abstract]
May T. Expanding Bioshield: a call for caution. Am J Public Health 2007 Apr;97(Suppl 1):S23-5 [Abstract]
McCarthy ML, Aronsky D, Kelen GD. The measurement of daily surge and its relevance to disaster preparedness. Acad Emerg Med 2006 Nov;13(11):1138-41 [Abstract]
McDade JE, Franz D. Bioterrorism as a public health threat. Emerg Infect Dis 1998;4(3):493-4 [Full text]
McGough M, Frank LL, Tipton S, et al. Communicating the risks of bioterrorism and other emergencies in a diverse society: a case study of special populations in North Dakota. Biosec Bioterr 2005 Sep;3(3):235-45 [Abstract]
Meredith LS, Eisenman DP, Rhodes H, et al. Trust influences response to public health messages during a bioterrorist event. J Health Commun 2007 Apr-May;12(3):217-32 [Abstract]
Miller J, Engelberg S, Broad W. Germs: biological weapons and America's secret war. New York, NY: Simon & Schuster, 2001
Moran GJ, Talan DA, Abrahamian FM. Biological terrorism. Infect Dis Clin N Am 2008 Mar;22(1):145-87 [Abstract]
Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004 Jul 8;430:242-9 [Abstract]
Mowatt-Larssen R. Al Queda weapons of mass destruction threat: hype or reality? Released Jan 26, 2010, from Harvard Kennedy School Belfer Center for Science and International Affairs [Full text]
Moye PK, Pesik N, Terndrup T, et al. Bioterrorism training in U.S. emergency medicine residencies: has it changed since 9/11? Acad Emerg Med 2007 Mar;14(3):221-7 [Abstract]
Mrvos R, Piposzar JD, Stein TM, et al. Regional pharmaceutical preparation for biological and chemical terrorism. J Toxicol Clin Toxicol 2003;41(1):17-21 [Abstract]
NACCT (National Advisory Committee on Children and Terrorism). Recommendations to the Secretary of HHS. Jun 12, 2003 [Full text]
National Academy of Sciences. Seeking security: pathogens, open access, and genome databases. National Academies Press. 2004 [Full text]
National Research Council of the National Academies. Protecting the frontline in biodefense research: the special immunizations program. May 11, 2011 [Full text]
National Research Council, Committee on the Atmospheric Dispersion of Hazardous Material Releases. Tracking and predicting the atmospheric dispersion of hazardous releases: implications for homeland security. Washington, DC: National Academies, 2003 [Full text]
National Research Council. Animal models for assessing countermeasures to bioterrorism agents. Dec 5, 2011 [Abstract]
National Research Council. Biotechnology research in an age of terrorism: confronting the "dual use" dilemma. Washington, DC: National Academies Press, 2003 (Prepublication copy) [Full text]
National Research Council. Biotechnology trends relevant to warfare initiatives. Chap 6 in: Avoiding surprise in an era of global technology advances. Washington, DC; National Academies Press, 2005 [Full text]
Nelson C, Chan EW, Chandra A, et al. Recommended infrastructure standards for mass antibiotic dispensing. (Rand report) Oct 10, 2008 [Full text]
Niedrig M, Schmitz H, Becker S, et al. First International Quality Assurance Study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol 2004 Apr;42(4):1753-5 [Abstract]
Niemeyer DM. The laboratory bioterrorism response network. J Homeland Security Mar 2002 [Full text]
Nightingale SL, Prasher JM, Simonson S. Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis 2007 Jul;13(7):1046-51 [Full text]
NIOSH (National Institute for Occupational Safety and Health). Guidance for protecting building environments from airborne chemical, biological, or radiological attacks. DHHS (NIOSH) Pub No. 2002-139, May 2002 [Full text]
NIOSH (National Institute for Occupational Safety and Health). Guidance on emergency responder personal protective equipment (PPE) for response to CBRN terrorism incidents. NIOSH pub no. 2008-132. Jun 2008 [Full text]
NIOSH (National Institute for Occupational Safety and Health). Recommendations for the selection and use of respirators and protective clothing for protection against biological agents. NIOSH Publication No. 2009-132. Released Apr 3, 2009 [Full text]
NIOSH/DHS (National Institute for Occupational Safety and Health/Department of Homeland Security). Guidance for filtration and air-cleaning systems to protect building environments from airborne chemical, biological, or radiological attacks. DHHS (NIOSH) Publication No. 2003-136. Apr 2003 [Full text]
Niska RW, Burt CW. Terrorism preparedness: have office-based physicians been trained? Fam Med 2007 May;39(5):357-65 [Abstract]
Niska RW, Burt CW. Training for terrorism-related conditions in hospitals: United States, 2003-04. Adv Data 2006 Dec 11;(380):1-9 [Full text]
Nolan JM, Samad EU, Jindra LF, et al. Seeking innovation: incentive funding for biodefense biotechs. Biosecur Bioterror 2010 Dec 10;8(4):365-72 [Abstract]
O'Brien KK, Higdon NL, Halverson JJ. Recognition and management of bioterrorism infections. Am Fam Physician 2003 May 1;67(9):1927-34 [Full text]
O'Toole T, Inglesby T. Facing the biological weapons threat. Lancet 2000;356(9236):1128-9 [Full text]
Osaka K, Takahashi H, Ohyama T. Testing a symptom-based surveillance system at high-profile gatherings as a preparatory measure for bioterrorism. Epidemiol Infect 2002 Dec;129(3):429-34 [Abstract]
Osterholm MT, Schwartz J. Living terrors: what America needs to know to survive the coming bioterrorist catastrophe. New York: Dalacorte Press, 2000
Osterholm MT. Bioterrorism: media hype or real potential nightmare? Am J Infect Control 1999;27(6):461-2 [Abstract]
Palacios G, Quan P-L, Jabado OJ, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007;13(1):73-81 [Full text]
Partnership for a Secure America. Biological terrorism: US policies to reduce global biothreats. Released Sep 10, 2008 [Full text]
Partnership for Public Service. Homeland insecurity: building the expertise to defend America from bioterrorism. Jun 6, 2003 [Full text]
Patt HA, Feigin RD. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective. Pediatrics 2002 Apr;109(4):685-92 [Abstract]
Peleg K, Kellermann AL. Enhancing hospital surge capacity for mass casualty events. (Commentary) JAMA 2009 Aug 5;302(5):562-4 [Extract]
Peruski AH, Johnson LH, Peruski LF. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J Immunol Methods 2002 May 1;263(1-2):35-41 [Abstract]
Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001 Feb 15;32(4):605-11 [Abstract]
Petro JB, Plasse TR, McNulty JA. Biotechnology: impact on biological warfare and biodefense. Biosecurity and Bioterrorism 2003;1(3):161-8 [Abstract]
Pien BC, Saah JR, Miller SE, et al. Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections. Clin Infect Dis 2006 May 1;42(9):1311-24 [Full text]
Pratt RJ. Invasive threats to the American homeland. US Army Professional Writing Collection. Spring 2004 [Full text]
Prior SD. Who you gonna call? Responding to a medical emergency with the Strategic National Stockpile. National Defense University. Released Jul 2004 [Full text]
Public Law 104-132. Antiterrorism and Effective Death Penalty Act of 1996 [Full text]
Public Law 104-201. National Defense Authority Act for Fiscal Year 1997 (weapons of mass destruction are addressed in title XIV) [Full text]
Public Law 107-188. Public Health Security and Bioterrorism Response Act. Jun 12, 2002 [Full text]
Raber E, Hibbard WJ, Greenwalt R. The national framework and consequence management guidance following a biological attack. Biosecur Bioterror 2011 Sep 1;9(3):271-9 [Abstract]
Raber E. The challenge of determining the need for remediation following a wide-area biological release. Biosecur Bioterror 2011 Sep 1;9(3):257-61 [Abstract]
Rabinowitz P, Gordon Z, Chudnov D,et al. Animals as sentinels of bioterrorism agents. Emerg Infect Dis 2006;12(4):647-52 [Full text]
Race MS, Hammond E. An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories. Biosecur Bioterror 2008 Mar;6(1):19-35 [Abstract]
Radosavljevic V, Jakovljevic B. Bioterrorism: types of epidemics, new epidemiological paradigm and levels of prevention. Public Health 2007 Jul;121(7):549-57 [Abstract]
RAND. Syndromic surveillance: an effective tool for detecting bioterrorism? RAND Center for Domestic and International Health Security. 2004 [Full text]
Rappert B. Codes of conduct and biological weapons: an in-process assessment. Biosecur Bioterror 2007 Jun;5(2):145-54 [Abstract]
Reaser JK, Clark EE Jr, Meyers NM. All creatures great and minute: a public policy primer for companion animal zoonoses. Zoonoses Public Health 2008 Oct;55(8-10):385-401 [Abstract]
Rebmann T, Citarella B, Alexander S, et al. Personal protective equipment use and allocation in home health during disasters. Am J Infect Control 2011 Dec;39(10):823-31 [Abstract]
Rebmann T, English JF, Carrico R. Disaster preparedness lessons learned and future directions for education: results from focus groups conducted at the 2006 APIC conference. Am J Infect Control 2007 Aug;35(6):374-81 [Abstract]
Rebmann T, Mohr LB. Missouri nurses' bioterrorism preparedness. Biosecur Bioterr 2008 Sep;6(3):243-52 [Abstract]
Relman DA. Bioterrorism: preparing to fight the next war. (Perspective) N Engl J Med 2006 Jan 12;3354(2):113-5 (includes link to interview with author) [Full text]
Reutter D, Schutzer SE, Craft CM, et al. Planning for exercises of chemical, biological, radiological, and nuclear (CBRN) forensic capabilities. Biosecur Bioterror 2010 Dec 10;8(4):343-55 [Abstract]
Richardson L. Buying biosafety: is the price right? N Engl J Med 2004 May 20;350(21):2121-3 [Full text]
Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8(2):225-30 [Full text]
Royal Society (United Kingdom). Making the UK safer: detecting and decontaminating chemical and biological agents. Apr 2004 [Full text]
Rubin JN. Recurring pitfalls in hospital preparedness and response. J Homeland Security 2004 Jan [Full text]
Rubinson L, Brnason RD, Pesik N, et al. Positive-pressure ventilation equipment for mass casualty respiratory failure. Biosec Bioterr 2006 Jun;4(2):183-94 [Abstract]
Russell PK. Vaccines in civilian defense against bioterrorism. Emerg Infect Dis 1999;5(4):492-3 [Full text]
Salerno RM, Hickok LT. Strengthening bioterrorism prevention: global biological materials management. Biosecur Bioterror 2007 Jun;5(2):107-16 [Abstract]
Salinsky E. Strong as the weakest link: medical response to a catastrophic event. National Health Policy Forum Background Paper No. 65 2008 Aug 8 [Full text]
Salinsky E. Will the nation be ready for the next bioterrorism attack? Mending gaps in the public health infrastructure. NHPF Issue Brief 2002 Jun 12;(776):1-19 [Abstract]
Sampath A, Metz M, Stundick M, et al. State-of-the-art therapeutic medical countermeasures for viral threat agents. Biosecur Bioterror 2011 (published online Nov 4) [Abstract]
Schoch-Spana M. Implications of pandemic influenza for bioterrorism response. Clin Infect Dis 2000 Dec;31(6):1409-13 [Abstract]
Schuler A. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006. Biosec Bioterr 2005 Jun;3(2) [Full text]
Schuler A. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005. Biosececurity Bioterrorism 2004;2(2):86-96
Scott TE, Bansal S, Mascarenhas AK. Willingness of New England dental professionals to provide assistance during a bioterrorism event. Biosecur Bioterr 2008 Sep;6(3):253-60 [Abstract]
Seshadri R, Paulsen IT, Eisen JA, et al. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl Acad Sci 2003 Apr 29;100(9):5455-60 [Abstract]
Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol 2003 Jul;41(7):2801-9 [Abstract]
Shadel BN, Rebmann T, Clements B, et al. Infection control practitioners' perceptions and educational needs regarding bioterrorism: Results from a national needs assessment survey. Am J Infect Control 2003 May;31(3):129-34 [Abstract]
Shalala DE. Bioterrorism: how prepared are we? Emerg Infect Dis 1999;5(4):492-3 [Full text]
Shapiro DS. Surge capacity for response to bioterrorism in hospital clinical microbiology laboratories. J Clin Microbiol 2003 Dec;41(12):5372-6 [Abstract]
Sharp TW, Brennan RJ, Keim M, et al. Medical preparedness for a terrorist incident involving chemical or biological agents during the 1996 Atlanta Olympic games. Ann Emerg Med 1998;32(2):214-23 [Abstract]
Shea DA, Gottron F. Small-scale terrorist attacks using chemical and biological agents: an assessment framework and preliminary comparisons. CRS Report for Congress. May 20, 2004 [Full text]
Shih FY, Koenig KL. Improving surge capacity for biothreats: experience from Taiwan. Acad Emerg Med 2006 Nov;13(11):1114-7 [Abstract]
Simon JD. Biological terrorism: preparing to meet the threat. JAMA 1997;278(5):428-30 [Abstract]
Sivitz LB, Stratton K, Benjamin GC, eds. Quarantine stations at ports of entry protecting the public's health. Institute of Medicine. 2005 [Full text]
Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 2006 Dec;4(4):351-5 [Abstract]
Smithson A, Levy LA. Ataxia: the chemical and biological terrorism threat and the US response. Washington, DC: Henry L. Stimson Center, 2000. Stimson Center Report No. 35. [Full text]
Snyder JW, Check W. Bioterrorism threats to our future: the role of the clinical microbiology laboratory in detection, identification, and confirmation of biological agents. 2001 [Full text]
Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis 2005 Oct;11(10):1629-32 [Full text]
Staiti AB, Katz A, Hoadley JF. Has bioterrorism preparedness improved public health? HSC (Center for Studying Health System Change). Issue Brief No. 65. Jul 2003 [Full text]
Stein BD, Tanielian TL, Vaiana ME, et al. The role of schools in meeting community needs during bioterrorism. Biosecur Bioterror 2003;1(4):273-81 [Abstract]
Stinson TF, Kinsey J, Degeneffe D, et al. How should America's anti-terrorism budget be allocated? Findings from a national survey of attitudes of U.S. residents about terrorism. Mar 2006 [Full text]
Strategic Assessments Group, Office of Transnational Issues. The darker bioweapons future. Nov 3, 2003 [Full text]
Suk JE, Zmorzynska A, Hunger I, et al. Dual-use research and technological diffusion: reconsidering the bioterrorism threat spectrum. (Opinion) PLoS Pathog 2011 Jan 13;7(1):e1001253 [Full text]
Syrett JI, Benitez JG, Livingston WH 3rd, et al. Will emergency health care providers respond to mass casualty incidents? J Healthc Prot Manage 2007;23(2):27-40 [Abstract]
Tegnell A, Bossi P, Baka A, et al. The European Commission's Task Force on Bioterrorism. Emerg Infect Dis 2003 Oct;9(10):1330-2 [Full text]
Temte JL, Anderson AL. Rapid assessment of agents of biological terrorism: defining the differential diagnosis of inhalational anthrax using electronic communication in a practice-based research network. Ann Fam Med 2004Oct/Nov;2(5):434-7 [Abstract]
Terriff CM, Schwartz MD, Lomaestro BM. Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2003 Mar;23(3):274-90 [Abstract]
Thompson KM, Armstrong RE, Thompson DF. Bayes, bugs and bioterrorists: lessons learned from the anthrax attacks. Center for Technology and National Security Policy, National Defense University. Apr 2005 [Full text]
Tokars JI, Burkom H, Xing J, et al. Enhancing time-series detection algorithms for automated biosurveillance. Emerg Infect Dis 2009 Apr;15(4):533-9 [Full text]
Toner ES, Nuzzo JB, Watson M, et al. Biosurveillance where it happens: state and local capabilities and needs. Biosecur Bioterror 2011 (published online Sep 9) [Abstract]
Torres-Urquidy MH, Wallstrom G, Schleyer TKL. Detection of disease outbreaks by the use of oral manifestations. J Dent Res 2009 Jan;88(1):89-94 [Abstract]
Treadwell TA, Koo D, Kuker K, et al. Epidemiologic clues to bioterrorism. Public Health Rep 2003 Mar-Apr;118(2):92-8 [Abstract]
Trust for America's Health. Blueprint for a healthier America: modernizing the federal public health system to focus on prevention and preparedness. Oct 21, 2008 [Links to full report, press release, & audio]
Trust for America's Health. Moving toward "all-hazards" public health preparedness. Written testimony of Shelly Hearne, Executive Director of Trust for America's Health, before the US House Committee on Government Reform. Feb 12, 2004 [Full text]
Trust for America's Health. Public health laboratories: unprepared and overwhelmed. June 2003 [Full text]
Trust for America's Health. Ready or not? Protecting the public's health from diseases, disasters, and bioterrorism, 2010. Released Dec 14, 2010 [Links to press release & full report]
Trust for America's Health. Ready or not? Protecting the public's health from diseases, disasters, and bioterrorism. Dec 20, 2011 [Full text]
Trust for America's Health. Ready or not? Protecting the public's health in the age of bioterrorism. Dec 2003 [Links to executive summary and full text]
Trust for America's Health. Ready or not? Protecting the public's health in the age of bioterrorism. Dec 2004 [Links to executive summary and full report]
Trust for America's Health. Remembering 9/11 and anthrax: public health's vital role in national defense. Sep 1, 2011 [Full text]
Trust for America's Health. Shortchanging America's health: a state by state look at how federal public health dollars are spent. Feb 2005 [Full text]
Tucker JB. The Biological Weapons Convention new process: a preliminary assessment. Nonproliferation Review 2004 Spring [Full text]
Turnbull W, Abhayaratne P. 2002 WMD terrorism chronology: incidents involving sub-national actors and chemical, biological, radiological, and nuclear materials. Aug 15, 2003 [Full text]
UK Food and Environment Research Agency. The decontamination of buildings, infrastructure and open environment exposed to chemical, biological, radiological or nuclear materials. Published Jan 31, 2011 [Full text]
UPMC Center for Biosecurity. A crossroads in biosecurity: steps to strengthen U.S. preparedness. Sep 8, 2011 [Full text]
UPMC Center for Biosecurity. Diagnostics for global biosurveillance: turning promising science into the tools needed in the field. Released Sep 13, 2011 (but dated July) [Full text]
UPMC Center for Biosecurity. How to lead during bioattacks with the public's trust and help: a manual for mayors, governors and top health officials. Biosec Bioterr 2004 Mar;2(1) [Introduction with links]
UPMC Center for Biosecurity. Preventing and deterring biological attacks: priorities that should emerge from the WMD Commission report. Dec 19, 2008 [Full text]
UPMC Center for Biosecurity. The state of biopreparedness: lessons from leaders, proposals for progress. Oct 27, 2010 [Full text]
US Commission on National Security/21st Century (Hart-Rudman Commission). Road map for national security: imperative for change (Feb 15, 2001)
US Government Accountability Office. National preparedness: DHS and HHS can further strengthen coordination for chemical, biological, radiological, and nuclear risk assessments. GAO-11-606. Jun 21, 2011 [Full text]
USAMRIID. Medical management of biological casualties handbook. Ed 4. Fort Detrick, Md: US Army Medical Research Institute of Infectious Diseases, 2001. [Full text]
Uscher-Pines L, Bookbinder S, Miro S, et al. From bioterrorism exercise to real-life public health crisis: lessons for emergency hotline operations. J Pub Health Manag Pract 2007 Jan/Feb;13(1):16-22 [Abstract]
VA (Department of Veteran's Affairs). Statement before the House Committee on Veteran's Affairs regarding the VA's ability to respond to DoD contingencies and to national emergencies. Oct 15, 2001 [Full text]
Vastag B. Bioterrorism threat calls for revisiting research. JAMA 2002 May 22:287(20):2639 [Full text]
Volkman JC, Rebmann T, Hilley S, et al. Infection prevention disaster preparedness planning for long-term care facilities. Am J Infect Control 2011 (published online Aug 16) [Abstract]
Waeckerle JF. Domestic preparedness for events involving weapons of mass destruction. JAMA 2000;283(2):252-4 [Full text]
Walden J, Kaplan EH. Estimating time and size of bioterror attack. Emerg Infect Dis 2004 Jul;10(7):1202-5 [Full text]
Wallerstein MB. Science in an age of terrorism. (Editorial) Science 2002 Sep 27;297:2169 [Full text]
Wang J, Yang Y, Zhou L, et al. Simultaneous detection of five biothreat agents in powder samples by a multiplexed suspension array. Immunopharm Immunotox 2009 Sep;31(3):417-27 [Abstract]
Wasserman J, Jacobson P, Lurie N, et al, for HHS. Organizing state and local health departments for public health preparedness. RAND Corp technical report series. 2006 [Full text]
Waterer GW, Robertson H. Bioterrorism for the respiratory physician. Respirology 2009 Jan;14(1):5-11 [Abstract]
Weapons of Mass Destruction Terrorism Research Program. Al-Qaida's WMD activities. Mar 2005 [Chart]
Wessely S. Commentary on "Terrorism, trauma, and mass casualty triage" [by Engel et al, above]. Biosecur Bioterror 2007 Jun;5(2):164-7 [Extract]
Wheelis M. Investigating disease outbreaks under a protocol to the Biological and Toxin Weapons Convention. Emerg Infect Dis 2000;6(6):595-600 [Full text]
Wheelis M. Will the new biology lead to new weapons? Arms Control Today 2004 Jul/Aug;34(6) [Full text]
White House Homeland Security Council. National strategy for homeland security. Released Oct 5, 2007 [Full text]
White House. Homeland Security Presidential Directive/HSPD-21: Public health and medical preparedness. Oct 18, 2007 [Full text]
WHO. Biological agents. Annex 3 in: Public health response to biological and chemical weapons: WHO guidance. Ed 2. 2004 [Full text]
WHO. Preparedness for the deliberate use of biological agents: a rational approach to the unthinkable. May 2002 [Full text]
WHO. Public health response to biological and chemical weapons: WHO guidance. Ed 2. 2004 [Full text]
Withers MR, Christopher GW. Aeromedical evacuation of biological warfare casualties: a treatise on infectious diseases on aircraft. Mil Med 2000 Nov;165(11 Suppl):1-21 [Abstract]
WMD Center. Bio-response report card. Oct 12, 2011 [Full text]
World Economic Forum. Global risks 2006 [Full text]
Wynia MK, Gostin L. The bioterrorist threat and access to health care. Science 2002;296(5573):1613 [Full text –Note: Registered users only]
Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 2005 Aug;11(8):1180-5 [Full text]
Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington, DC: Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center 1997 [Full text]
Zalewski S, Vinker S, Monnickendam S, et al. Israel under threat of biological warfare--the reactions of our patients during the 1998 Persian Gulf crisis. Fam Med 2000;32(5):342-5 [Abstract]
Zerwekh T, McKnight J, Hupert N, et al. Mass medication modeling in response to public health emergencies: outcomes of a drive-thru exercise. J Pub Health Manag Pract 2007 Jan/Feb;13(1):7-15 [Abstract]
Zillinskas RA. Bioterrorism Threat Assessment and Risk Management Workshop: final report and commentary. Jun 24, 2003 [Full text]
Zillinskas RA. Iraq's biological weapons: the past as future? JAMA 1997;278(5):418-24 [Abstract]
Zmorzynska A, Suk JE, Biederbick W, et al. Unfinished business: efforts to define dual-use research of bioterrorism concern. Biosecur Bioterror 2011 Dec 1;9(4):e372-8 [Abstract]
|
